| Date Filed | Type | Description |
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/01/2021 |
4
| Nuechterlein Carole (Director) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Granted 23,552 options to buy
@ $20, valued at
$471k
|
|
| 10/28/2021 |
3
| Nuechterlein Carole (Director) has filed a Form 3 on Entrada Therapeutics, Inc. |
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/20/2020 |
4
| Nuechterlein Carole (Director) has filed a Form 4 on Aligos Therapeutics, Inc.|
Txns:
| Converted 2,145,991 shares
@ $0
Converted 662,799 shares
@ $0
Converted 283,550 shares
@ $0
Converted 2,145,991 preferred shares
@ $0
Converted 662,799 preferred shares
@ $0
Converted 283,550 preferred shares
@ $0 |
|
| 10/15/2020 |
3
| Nuechterlein Carole (Director) has filed a Form 3 on Aligos Therapeutics, Inc. |
| 09/03/2020 |
3
| Nuechterlein Carole (Director) has filed a Form 3 on BCTG Acquisition Corp. |
| 06/23/2020 |
4
| Nuechterlein Carole (Director) has filed a Form 4 on Millendo Therapeutics, Inc.|
Txns:
| Granted 12,000 options to buy
@ $2.4, valued at
$28.8k
|
|
| 06/21/2019 |
4
| Nuechterlein Carole (Director) has filed a Form 4 on Millendo Therapeutics, Inc.|
Txns:
| Granted 12,000 options to buy
@ $11.59, valued at
$139.1k
|
|
| 01/17/2019 |
4
| Nuechterlein Carole (Director) has filed a Form 4 on Millendo Therapeutics, Inc.|
Txns:
| Granted 6,000 options to buy
@ $8.8, valued at
$52.8k
|
|
| 12/11/2018 |
3
| Nuechterlein Carole (Director) has filed a Form 3 on Millendo Therapeutics, Inc. |
| 02/12/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/10/2016 |
3
| Nuechterlein Carole (Director) has filed a Form 3 on AveXis, Inc. |